Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 271

1.

The effect of incentive-based formularies on prescription-drug utilization and spending.

Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Frank RG.

N Engl J Med. 2003 Dec 4;349(23):2224-32.

2.

Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.

Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Muriel AC, Frank RG.

Arch Gen Psychiatry. 2005 Apr;62(4):435-41.

3.

Effect of tiered prescription copayments on the use of preferred brand medications.

Rector TS, Finch MD, Danzon PM, Pauly MV, Manda BS.

Med Care. 2003 Mar;41(3):398-406.

PMID:
12618643
4.

Incentive formularies and changes in prescription drug spending.

Landon BE, Rosenthal MB, Normand SL, Spettell C, Lessler A, Underwood HR, Newhouse JP.

Am J Manag Care. 2007 Jun;13(6 Pt 2):360-9.

5.
6.

Effect of a three-tier prescription copay on pharmaceutical and other medical utilization.

Motheral B, Fairman KA.

Med Care. 2001 Dec;39(12):1293-304.

PMID:
11717571
7.

Employer drug benefit plans and spending on prescription drugs.

Joyce GF, Escarce JJ, Solomon MD, Goldman DP.

JAMA. 2002 Oct 9;288(14):1733-9. Erratum in: JAMA 2002 Nov 20;288(19):2409.

PMID:
12365957
8.

The effect of a three-tier formulary on antidepressant utilization and expenditures.

Hodgkin D, Parks Thomas C, Simoni-Wastila L, Ritter GA, Lee S.

J Ment Health Policy Econ. 2008 Jun;11(2):67-77.

PMID:
18509214
9.

Controlling prescription drug expenditures: a report of success.

Miller DP, Furberg CD, Small RH, Millman FM, Ambrosius WT, Harshbarger JS, Ohl CA.

Am J Manag Care. 2007 Aug;13(8):473-80.

10.

Incentive-based formularies.

Thomas CP.

N Engl J Med. 2003 Dec 4;349(23):2186-8. No abstract available.

PMID:
14657424
11.

Three-tiered-copayment drug coverage and use of nonsteroidal anti-inflammatory drugs.

Briesacher B, Kamal-Bahl S, Hochberg M, Orwig D, Kahler KH.

Arch Intern Med. 2004 Aug 9-23;164(15):1679-84.

PMID:
15302639
12.

Consumer response to dual incentives under multitiered prescription drug formularies.

Gilman BH, Kautter J.

Am J Manag Care. 2007 Jun;13(6 Pt 2):353-9.

13.

Impact of cost sharing on prescription drugs used by Medicare beneficiaries.

Goedken AM, Urmie JM, Farris KB, Doucette WR.

Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7.

PMID:
20511109
14.

The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions.

Shrank WH, Hoang T, Ettner SL, Glassman PA, Nair K, DeLapp D, Dirstine J, Avorn J, Asch SM.

Arch Intern Med. 2006 Feb 13;166(3):332-7.

PMID:
16476874
15.

Are incentive-based formularies inversely associated with drug utilization in managed care?

Gleason PP, Gunderson BW, Gericke KR.

Ann Pharmacother. 2005 Feb;39(2):339-45. Epub 2005 Jan 11. Review.

PMID:
15644478
16.

A bitter pill: formulary variability and the challenge to prescribing physicians.

Shrank WH, Ettner SL, Glassman P, Asch SM.

J Am Board Fam Pract. 2004 Nov-Dec;17(6):401-7.

17.

Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization.

Landsman PB, Yu W, Liu X, Teutsch SM, Berger ML.

Am J Manag Care. 2005 Oct;11(10):621-8.

18.

A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.

Clark BE, Siracuse MV, Garis RI.

Res Social Adm Pharm. 2009 Jun;5(2):133-42. doi: 10.1016/j.sapharm.2008.06.002. Epub 2009 Jan 31.

PMID:
19524861
19.

Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.

Klepser DG, Huether JR, Handke LJ, Williams CE.

J Manag Care Pharm. 2007 Nov-Dec;13(9):765-77.

20.

Impact of health plan design and management on retirees' prescription drug use and spending, 2001.

Thomas CP, Wallack SS, Lee S, Ritter GA.

Health Aff (Millwood). 2002 Jul-Dec;Suppl Web Exclusives:W408-19.

PMID:
12703602

Supplemental Content

Support Center